Loading…

Enhancing Therapeutic Effects of Photodynamic Therapy with 5-Aminolevulinic Acid Using Polymeric Iron Chelators

5-Aminolevulinic acid (5-ALA) is commonly used in photodynamic therapy (PDT) and photodiagnosis. 5-ALA is converted into protoporphyrin IX (PpIX), which exerts phototoxicity upon photoirradiation in many kinds of cancer cells [1]. However, it has been suggested that tumoral iron sometimes compromise...

Full description

Saved in:
Bibliographic Details
Published in:Photodiagnosis and photodynamic therapy 2023-03, Vol.41, p.103430, Article 103430
Main Authors: GUO, Haochen, NOMOTO, Takahiro, KOMOTO, Kana, NAGANO, Tomoya, ISHII, Takuya, HONDA, Yuto, OGURA, Shun-ichiro, ISHIZUKA, Masahiro, NISHIYAMA, Nobuhiro
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page 103430
container_title Photodiagnosis and photodynamic therapy
container_volume 41
creator GUO, Haochen
NOMOTO, Takahiro
KOMOTO, Kana
NAGANO, Tomoya
ISHII, Takuya
HONDA, Yuto
OGURA, Shun-ichiro
ISHIZUKA, Masahiro
NISHIYAMA, Nobuhiro
description 5-Aminolevulinic acid (5-ALA) is commonly used in photodynamic therapy (PDT) and photodiagnosis. 5-ALA is converted into protoporphyrin IX (PpIX), which exerts phototoxicity upon photoirradiation in many kinds of cancer cells [1]. However, it has been suggested that tumoral iron sometimes compromises the PDT effect of 5-ALA by promoting the metabolization of PpIX to the non-phototoxic heme [2]. In this context, inactivating tumoral iron via an iron chelator is expected to improve the accumulation of 5-ALA-induced PpIX in tumors and enhance the therapeutic effect. Indeed, previous studies have successfully enhanced in vitro phototoxicity of 5-ALA using iron chelators including deferoxamine (DFO), which is the clinically approved chelator for iron overload. However, only a few studies reported the promise of such iron chelators in in vivo probably because of insufficient tumor accumulation of the iron chelators, as it is well known that intravenously injected DFO is quickly cleared from the body. In this regard, we recently developed a polymeric iron chelator by conjugating multiple DFO molecules on the side chain of a poly(ethylene glycol)-poly(aspartic acid). The polymeric iron chelator, termed PDFO, showed prolonged blood retention and higher tumor accumulation than conventional DFO through the enhanced permeability and retention effect [3]. Here, we investigated the effect of PDFO on the PDT efficiency with 5-ALA hydrochloride. In in vitro study, PDFO as well as DFO decreased the intercellular iron and enhanced the PpIX accumulation and phototoxicity to cancer cells. Importantly, in in vivo study, DFO did not enhance the PDT effect of 5-ALA hydrochloride; however, PDFO exhibited significantly enhanced therapeutic efficacy in subcutaneous tumor models. These results suggest that PDFO could be a promising polymer for enhancing therapeutic efficacy of 5-ALA hydrochloride.
doi_str_mv 10.1016/j.pdpdt.2023.103430
format article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1016_j_pdpdt_2023_103430</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1572100023001576</els_id><sourcerecordid>S1572100023001576</sourcerecordid><originalsourceid>FETCH-LOGICAL-c980-49f942a982af72c620c493af0a0ba5c2a2c68ea871c6ad53a8260ac9519c4b163</originalsourceid><addsrcrecordid>eNp9kM1OwzAQhC0EEqXwBFz8Ain-yZ8PHKqqQCUkeihna-vYxFViR3ZalLfHpZw57Wp2ZrT6EHqkZEEJLZ8Oi6EZmnHBCONJ4TknV2hG64pntBDVddqLimWUEHKL7mI8kOQRJJ8hv3YtOGXdF961OsCgj6NVeG2MVmPE3uBt60ffTA76pF88E_62Y4uLbNlb5zt9OnbWpetS2QZ_xnPZ1ndTr0MSN8E7vGp1B6MP8R7dGOiifvibc7R7We9Wb9n7x-tmtXzPlKhJlgsjcgaiZmAqpkpGVC44GAJkD4VikLRaQ11RVUJTcKhZSUCJggqV72nJ54hfalXwMQZt5BBsD2GSlMgzMnmQv8jkGZm8IEup50tKp89OVgcZldVO6caGhEM23v6b_wG-D3c1</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Enhancing Therapeutic Effects of Photodynamic Therapy with 5-Aminolevulinic Acid Using Polymeric Iron Chelators</title><source>Elsevier</source><creator>GUO, Haochen ; NOMOTO, Takahiro ; KOMOTO, Kana ; NAGANO, Tomoya ; ISHII, Takuya ; HONDA, Yuto ; OGURA, Shun-ichiro ; ISHIZUKA, Masahiro ; NISHIYAMA, Nobuhiro</creator><creatorcontrib>GUO, Haochen ; NOMOTO, Takahiro ; KOMOTO, Kana ; NAGANO, Tomoya ; ISHII, Takuya ; HONDA, Yuto ; OGURA, Shun-ichiro ; ISHIZUKA, Masahiro ; NISHIYAMA, Nobuhiro</creatorcontrib><description>5-Aminolevulinic acid (5-ALA) is commonly used in photodynamic therapy (PDT) and photodiagnosis. 5-ALA is converted into protoporphyrin IX (PpIX), which exerts phototoxicity upon photoirradiation in many kinds of cancer cells [1]. However, it has been suggested that tumoral iron sometimes compromises the PDT effect of 5-ALA by promoting the metabolization of PpIX to the non-phototoxic heme [2]. In this context, inactivating tumoral iron via an iron chelator is expected to improve the accumulation of 5-ALA-induced PpIX in tumors and enhance the therapeutic effect. Indeed, previous studies have successfully enhanced in vitro phototoxicity of 5-ALA using iron chelators including deferoxamine (DFO), which is the clinically approved chelator for iron overload. However, only a few studies reported the promise of such iron chelators in in vivo probably because of insufficient tumor accumulation of the iron chelators, as it is well known that intravenously injected DFO is quickly cleared from the body. In this regard, we recently developed a polymeric iron chelator by conjugating multiple DFO molecules on the side chain of a poly(ethylene glycol)-poly(aspartic acid). The polymeric iron chelator, termed PDFO, showed prolonged blood retention and higher tumor accumulation than conventional DFO through the enhanced permeability and retention effect [3]. Here, we investigated the effect of PDFO on the PDT efficiency with 5-ALA hydrochloride. In in vitro study, PDFO as well as DFO decreased the intercellular iron and enhanced the PpIX accumulation and phototoxicity to cancer cells. Importantly, in in vivo study, DFO did not enhance the PDT effect of 5-ALA hydrochloride; however, PDFO exhibited significantly enhanced therapeutic efficacy in subcutaneous tumor models. These results suggest that PDFO could be a promising polymer for enhancing therapeutic efficacy of 5-ALA hydrochloride.</description><identifier>ISSN: 1572-1000</identifier><identifier>EISSN: 1873-1597</identifier><identifier>DOI: 10.1016/j.pdpdt.2023.103430</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>5-aminolevulinic acid ; deferoxamine ; iron chelation ; polymer</subject><ispartof>Photodiagnosis and photodynamic therapy, 2023-03, Vol.41, p.103430, Article 103430</ispartof><rights>2023</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>GUO, Haochen</creatorcontrib><creatorcontrib>NOMOTO, Takahiro</creatorcontrib><creatorcontrib>KOMOTO, Kana</creatorcontrib><creatorcontrib>NAGANO, Tomoya</creatorcontrib><creatorcontrib>ISHII, Takuya</creatorcontrib><creatorcontrib>HONDA, Yuto</creatorcontrib><creatorcontrib>OGURA, Shun-ichiro</creatorcontrib><creatorcontrib>ISHIZUKA, Masahiro</creatorcontrib><creatorcontrib>NISHIYAMA, Nobuhiro</creatorcontrib><title>Enhancing Therapeutic Effects of Photodynamic Therapy with 5-Aminolevulinic Acid Using Polymeric Iron Chelators</title><title>Photodiagnosis and photodynamic therapy</title><description>5-Aminolevulinic acid (5-ALA) is commonly used in photodynamic therapy (PDT) and photodiagnosis. 5-ALA is converted into protoporphyrin IX (PpIX), which exerts phototoxicity upon photoirradiation in many kinds of cancer cells [1]. However, it has been suggested that tumoral iron sometimes compromises the PDT effect of 5-ALA by promoting the metabolization of PpIX to the non-phototoxic heme [2]. In this context, inactivating tumoral iron via an iron chelator is expected to improve the accumulation of 5-ALA-induced PpIX in tumors and enhance the therapeutic effect. Indeed, previous studies have successfully enhanced in vitro phototoxicity of 5-ALA using iron chelators including deferoxamine (DFO), which is the clinically approved chelator for iron overload. However, only a few studies reported the promise of such iron chelators in in vivo probably because of insufficient tumor accumulation of the iron chelators, as it is well known that intravenously injected DFO is quickly cleared from the body. In this regard, we recently developed a polymeric iron chelator by conjugating multiple DFO molecules on the side chain of a poly(ethylene glycol)-poly(aspartic acid). The polymeric iron chelator, termed PDFO, showed prolonged blood retention and higher tumor accumulation than conventional DFO through the enhanced permeability and retention effect [3]. Here, we investigated the effect of PDFO on the PDT efficiency with 5-ALA hydrochloride. In in vitro study, PDFO as well as DFO decreased the intercellular iron and enhanced the PpIX accumulation and phototoxicity to cancer cells. Importantly, in in vivo study, DFO did not enhance the PDT effect of 5-ALA hydrochloride; however, PDFO exhibited significantly enhanced therapeutic efficacy in subcutaneous tumor models. These results suggest that PDFO could be a promising polymer for enhancing therapeutic efficacy of 5-ALA hydrochloride.</description><subject>5-aminolevulinic acid</subject><subject>deferoxamine</subject><subject>iron chelation</subject><subject>polymer</subject><issn>1572-1000</issn><issn>1873-1597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kM1OwzAQhC0EEqXwBFz8Ain-yZ8PHKqqQCUkeihna-vYxFViR3ZalLfHpZw57Wp2ZrT6EHqkZEEJLZ8Oi6EZmnHBCONJ4TknV2hG64pntBDVddqLimWUEHKL7mI8kOQRJJ8hv3YtOGXdF961OsCgj6NVeG2MVmPE3uBt60ffTA76pF88E_62Y4uLbNlb5zt9OnbWpetS2QZ_xnPZ1ndTr0MSN8E7vGp1B6MP8R7dGOiifvibc7R7We9Wb9n7x-tmtXzPlKhJlgsjcgaiZmAqpkpGVC44GAJkD4VikLRaQ11RVUJTcKhZSUCJggqV72nJ54hfalXwMQZt5BBsD2GSlMgzMnmQv8jkGZm8IEup50tKp89OVgcZldVO6caGhEM23v6b_wG-D3c1</recordid><startdate>202303</startdate><enddate>202303</enddate><creator>GUO, Haochen</creator><creator>NOMOTO, Takahiro</creator><creator>KOMOTO, Kana</creator><creator>NAGANO, Tomoya</creator><creator>ISHII, Takuya</creator><creator>HONDA, Yuto</creator><creator>OGURA, Shun-ichiro</creator><creator>ISHIZUKA, Masahiro</creator><creator>NISHIYAMA, Nobuhiro</creator><general>Elsevier B.V</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>202303</creationdate><title>Enhancing Therapeutic Effects of Photodynamic Therapy with 5-Aminolevulinic Acid Using Polymeric Iron Chelators</title><author>GUO, Haochen ; NOMOTO, Takahiro ; KOMOTO, Kana ; NAGANO, Tomoya ; ISHII, Takuya ; HONDA, Yuto ; OGURA, Shun-ichiro ; ISHIZUKA, Masahiro ; NISHIYAMA, Nobuhiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c980-49f942a982af72c620c493af0a0ba5c2a2c68ea871c6ad53a8260ac9519c4b163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>5-aminolevulinic acid</topic><topic>deferoxamine</topic><topic>iron chelation</topic><topic>polymer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>GUO, Haochen</creatorcontrib><creatorcontrib>NOMOTO, Takahiro</creatorcontrib><creatorcontrib>KOMOTO, Kana</creatorcontrib><creatorcontrib>NAGANO, Tomoya</creatorcontrib><creatorcontrib>ISHII, Takuya</creatorcontrib><creatorcontrib>HONDA, Yuto</creatorcontrib><creatorcontrib>OGURA, Shun-ichiro</creatorcontrib><creatorcontrib>ISHIZUKA, Masahiro</creatorcontrib><creatorcontrib>NISHIYAMA, Nobuhiro</creatorcontrib><collection>CrossRef</collection><jtitle>Photodiagnosis and photodynamic therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>GUO, Haochen</au><au>NOMOTO, Takahiro</au><au>KOMOTO, Kana</au><au>NAGANO, Tomoya</au><au>ISHII, Takuya</au><au>HONDA, Yuto</au><au>OGURA, Shun-ichiro</au><au>ISHIZUKA, Masahiro</au><au>NISHIYAMA, Nobuhiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Enhancing Therapeutic Effects of Photodynamic Therapy with 5-Aminolevulinic Acid Using Polymeric Iron Chelators</atitle><jtitle>Photodiagnosis and photodynamic therapy</jtitle><date>2023-03</date><risdate>2023</risdate><volume>41</volume><spage>103430</spage><pages>103430-</pages><artnum>103430</artnum><issn>1572-1000</issn><eissn>1873-1597</eissn><abstract>5-Aminolevulinic acid (5-ALA) is commonly used in photodynamic therapy (PDT) and photodiagnosis. 5-ALA is converted into protoporphyrin IX (PpIX), which exerts phototoxicity upon photoirradiation in many kinds of cancer cells [1]. However, it has been suggested that tumoral iron sometimes compromises the PDT effect of 5-ALA by promoting the metabolization of PpIX to the non-phototoxic heme [2]. In this context, inactivating tumoral iron via an iron chelator is expected to improve the accumulation of 5-ALA-induced PpIX in tumors and enhance the therapeutic effect. Indeed, previous studies have successfully enhanced in vitro phototoxicity of 5-ALA using iron chelators including deferoxamine (DFO), which is the clinically approved chelator for iron overload. However, only a few studies reported the promise of such iron chelators in in vivo probably because of insufficient tumor accumulation of the iron chelators, as it is well known that intravenously injected DFO is quickly cleared from the body. In this regard, we recently developed a polymeric iron chelator by conjugating multiple DFO molecules on the side chain of a poly(ethylene glycol)-poly(aspartic acid). The polymeric iron chelator, termed PDFO, showed prolonged blood retention and higher tumor accumulation than conventional DFO through the enhanced permeability and retention effect [3]. Here, we investigated the effect of PDFO on the PDT efficiency with 5-ALA hydrochloride. In in vitro study, PDFO as well as DFO decreased the intercellular iron and enhanced the PpIX accumulation and phototoxicity to cancer cells. Importantly, in in vivo study, DFO did not enhance the PDT effect of 5-ALA hydrochloride; however, PDFO exhibited significantly enhanced therapeutic efficacy in subcutaneous tumor models. These results suggest that PDFO could be a promising polymer for enhancing therapeutic efficacy of 5-ALA hydrochloride.</abstract><pub>Elsevier B.V</pub><doi>10.1016/j.pdpdt.2023.103430</doi></addata></record>
fulltext fulltext
identifier ISSN: 1572-1000
ispartof Photodiagnosis and photodynamic therapy, 2023-03, Vol.41, p.103430, Article 103430
issn 1572-1000
1873-1597
language eng
recordid cdi_crossref_primary_10_1016_j_pdpdt_2023_103430
source Elsevier
subjects 5-aminolevulinic acid
deferoxamine
iron chelation
polymer
title Enhancing Therapeutic Effects of Photodynamic Therapy with 5-Aminolevulinic Acid Using Polymeric Iron Chelators
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T17%3A54%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Enhancing%20Therapeutic%20Effects%20of%20Photodynamic%20Therapy%20with%205-Aminolevulinic%20Acid%20Using%20Polymeric%20Iron%20Chelators&rft.jtitle=Photodiagnosis%20and%20photodynamic%20therapy&rft.au=GUO,%20Haochen&rft.date=2023-03&rft.volume=41&rft.spage=103430&rft.pages=103430-&rft.artnum=103430&rft.issn=1572-1000&rft.eissn=1873-1597&rft_id=info:doi/10.1016/j.pdpdt.2023.103430&rft_dat=%3Celsevier_cross%3ES1572100023001576%3C/elsevier_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c980-49f942a982af72c620c493af0a0ba5c2a2c68ea871c6ad53a8260ac9519c4b163%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true